Supplementary Figure 1: Hematoxylin and eosin and Luxol fast blue staining show absence of overt inflammation and demyelinating lesions.
From: Epigenome-wide differences in pathology-free regions of multiple sclerosis–affected brains
(a) Representative hematoxylin and eosin staining for control (n=5 brain samples) and multiple sclerosis (n=15 brain samples) sections shows an absence of inflammatory infiltrates. (b) Representative Luxol fast blue staining for control (n=5 brain samples) and multiple sclerosis (n=15 brain samples) sections shows an absence of demyelinating lesions. Scale bar = 100 μm. NAWM, normal-appearing white matter.
